In a single institutional review of 1185 breast cancer cases using multi-gene panel testing (MGPT), a high occurrence of bilateral tumors was observed in 26.3% of the ATM germline variant carriers and in as much as 41.2% of CHEK2 variant carriers [26]. Here, ATM is linked to breast cancer.